白血病 弥漫性内生性脑胶质瘤(DIPG) 膀胱癌 脑胶质瘤 增生性小圆细胞瘤（DSRCT） |
Case 1: Leukemia Case 2: Diffuse Intrinsic Pontine Glioma (DIPG) Case 3: Bladder Cancer Case 4: Glioma Case 5: Desmoplastic Small Round Cell Tumor (DSRCT) |
(1) Patient Condition Overview: The patient was diagnosed with a rare chronic leukemia (blood cancer) three years before the case service, having received treatment at multiple domestic medical institutions without significant improvement. In 2017, the patient's condition suddenly deteriorated and he was transferred to a leading domestic oncology specialty hospital.
(2) Service Need Initiation: To obtain advanced international treatment ideas, control the patient's condition, and seek better treatment plans, experts from the leading domestic oncology specialty hospital formally applied to E-Health Now for international medical services, with the core need being to connect with American hematology experts.
(1) Preliminary Document Preparation and Processing:
· The patient and family completed user registration on the E-Health Now platform, submitted a brief condition description, and uploaded core medical documents (including case files, scanned laboratory reports, high-definition images of blood smears, etc.).
· E-Health Now immediately initiated professional medical translation services, accurately translating all Chinese medical materials into English to ensure clear interpretation by international experts.
(2) International Expert Matching and Scheduling:
· Addressing the pain point of "high difficulty in matching rare disease experts," E-Health Now, through professional screening and coordination, successfully scheduled an American hematology expert with global influence in the rare chronic leukemia field within three business days.
(3) Remote Consultation Implementation:
· After scheduling, a three-party remote consultation among the patient, attending Chinese physician, and American expert was organized on the E-Health Now platform within the same week, focusing on in-depth discussion of the patient's condition.
(4) Consultation Report Delivery:
· Within 8 hours after the remote consultation, the Comprehensive Diagnosis and Treatment Recommendation Report was delivered to the patient and attending Chinese physician in both Chinese and English, ensuring rapid implementation of recommendations.
· After the consultation, E-Health Now established a long-term communication channel through its secure digital platform to ensure ongoing contact among the patient, domestic doctors, and American experts.
· Two weeks after the consultation, at the request of the patient and domestic experts, E-Health Now assisted in initiating a second consultation with the same American expert to discuss the patient's latest physiological test results and further optimize the treatment plan.
· The patient, family members, and attending Chinese experts gave unanimous praise for E-Health Now's service quality (including response speed, expert matching accuracy, and report delivery efficiency) and the final service outcomes, and actively recommended the service.
A 13-year-old patient developed diplopia, inability to maintain balance while walking, and dysphagia at the end of September 2017. A CT scan of the head revealed a lesion in the brainstem, and a subsequent brain MRI confirmed the symptoms and imaging findings were consistent with Diffuse Intrinsic Pontine Glioma (DIPG). After unsuccessful treatment at several specialized medical institutions in China, a renowned domestic specialist applied to E-Health Now for service, hoping to consult American glioma experts for overseas treatment recommendations and timely disease control.
The experts offered several feasible options. After multi-party discussion, it was decided to use the current CED (Convection Enhanced Delivery) treatment technology and to arrange for overseas treatment in the United States. The patient, family members, and Chinese experts all expressed unanimous satisfaction and praise for the quality and outcomes of E-Health Now's service. Through E-Health Now's secure digital platform, the patient, Chinese physicians, and American experts maintained contact. After the patient completed the pre-treatment radiotherapy course and examinations domestically in approximately one and a half months, the patient and family successfully went to the United States for follow-up treatment with E-Health Now's assistance.
The patient and family registered on the E-Health Now platform, submitted a brief condition description, and uploaded the required documents: scanned medical records and laboratory reports, brain MRI, etc. E-Health Now initiated professional medical translation. Despite the rarity of the condition and the challenges in finding international experts, E-Health Now's professional bespoke service successfully scheduled two globally influential American pediatric glioma experts within three business days. The remote consultation with international experts was completed on the E-Health Now platform within the same week. Within eight hours of the consultation, the patient and Chinese doctors received a tailored plan and report in both Chinese and English.
A 55-year-old male patient with bladder cancer presented with multiple tumors in the bladder. There was disagreement among Chinese physicians regarding whether to proceed with surgery first or chemotherapy first. The patient turned to E-Health Now for advice from international experts, hoping to be connected with American uro-oncology specialists to learn about overseas treatment recommendations, control the disease, and access advanced therapies and treatment options.
Within four business days, E-Health Now invited Dr. Bradley McGregor and Dr. Adam Stuart Kibel, both Chiefs of Urological Internal Medicine and Surgery at Dana-Farber Cancer Institute in the United States, to join a Sino-American remote multidisciplinary consultation. Ten domestic and international experts from Peking University First Hospital, the National Cancer Center/Cancer Hospital of the Chinese Academy of Medical Sciences, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, and Xinqiao Hospital, covering oncology, urology, medical imaging, and other specialties, also participated. Based on the available examination data, both American experts unanimously agreed that neoadjuvant chemotherapy before surgery was beneficial for the patient's survival. There is currently no clear evidence that postoperative chemotherapy benefits patient survival, and 50% of patients cannot tolerate chemotherapy after radical cystectomy. Therefore, they recommended neoadjuvant chemotherapy first. Chinese physicians also raised their own views and questions during the consultation. Within 48 hours after the consultation, the patient and Chinese doctors received a tailored treatment plan in both Chinese and English.
After the consultation, based on the American experts' recommendations and the opinions of the Chinese expert team, the patient reached a consensus to change the original domestic treatment plan, adopting neoadjuvant chemotherapy first, followed by elective surgery. The consultation results were recognized by the patient, family members, and Chinese experts.
A 42-year-old male patient with glioma was diagnosed with oligoastrocytoma and underwent tumor resection. The patient and family contacted E-Health Now, seeking experts from MD Anderson Cancer Center in the United States. The patient was eager to travel to the US for proton therapy and wanted to learn about specific comprehensive treatment plans and estimated survival period.
First, E-Health Now assisted the patient in registering on the platform, translated the medical records into English, and helped obtain DICOM imaging data from the hospital where the surgery was performed, uploading it to the system. Within three business days, E-Health Now contacted Dr. John F. de Groot, Chief of Neuro-Oncology at MD Anderson Cancer Center, to conduct a Sino-American remote multidisciplinary consultation with a chief physician specializing in neuro-oncology from a Chinese hospital. The American expert stated that the current condition was relatively stable, and close observation or proton therapy combined with other drug treatments could be considered, both of which can be performed 6-9 months after surgery. Effective treatment can extend the patient's survival and reduce toxicity to the brain, especially for younger patients. Within 48 hours of the consultation, the patient and Chinese doctors received tailored treatment recommendations in both Chinese and English.
After the consultation, the patient and family actively prepared the procedures for overseas medical treatment in the United States and decided to go abroad for follow-up treatment. Chinese and foreign doctors, as well as the patient's family, expressed satisfaction with the efficiency and quality of E-Health Now's service.
A 26-year-old male patient with Desmoplastic Small Round Cell Tumor (DSRCT) presented with progressively worsening abdominal cramps. Examination led to a diagnosis of mesenchymal-origin tumor, a rare and highly malignant, invasive tumor with only approximately 200 cases diagnosed worldwide since its discovery. After treatment at multiple domestic hospitals, the patient and family hoped to seek diagnostic and treatment opinions from American sarcoma research experts.
First, E-Health Now assisted the patient in registering on the platform, translated the medical records into English, and uploaded them to the system. Within three business days, E-Health Now contacted Dr. Sant P. Chawla, Professor and Director of the Sarcoma Oncology Center in Southern California, and Professor at MD Anderson Cancer Center, who has been engaged in sarcoma-related research for many years. Simultaneously, the Chief of Oncology Chemotherapy at Peking University First Hospital was invited for a Sino-American remote consultation. Based on comparison of the patient's pre- and post-CT imaging progression, the current condition was assessed as generally stable, with minor progression in some lesions. Chinese and American doctors reached a consensus on treatment: continue the original chemotherapy drugs, add a PD-1 inhibitor, and re-examine with CT after 6 months. If treatment proves ineffective, the patient could consider participating in the Yondelis clinical trial of a new drug in the United States. Within 48 hours of the consultation, the patient and Chinese doctors received tailored treatment recommendations in both Chinese and English.
After consulting with multiple renowned oncologists both domestically and internationally, the patient and family decided to start PD-1 treatment, with ongoing monitoring of therapeutic effects. Chinese and foreign doctors, as well as the patient's family, expressed satisfaction with the efficiency and quality of E-Health Now's service.
|
|
Address: Rooms 509 & 609, Building 237 Chaoyang North Road, Fosun International Center, Chaoyang District, Beijing
E-mail: hmhlservice@ehealthnow.cn
WeChat Official Account